COSS

Biovista’s COSS™ platform is a hybrid approach, combining literature-based discovery with in silico simulations and resource mining to develop ranked lists of outcomes that answer a host of drug development questions.

At its core COSS™ creates multi-dimensional profiles of biologically relevant entities such as genes, pathways, diseases and adverse events from public and other sources. Biases are minimized through an include-all-information extraction process and the ability to analyze a problem from multiple viewpoints.


Home page of this offering   provided by Biovista